Skin Cancer Diagnostics Market 2027 By Cancer Type, Diagnosis, and geography | The Insight Partners

Skin Cancer Diagnostics Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Cancer Type (Melanoma, Non-melanoma); Diagnosis (Dermatoscopy, Biopsy, Genetic Tests, Others), and geography

Report Code: TIPRE00018116 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Typically, diagnosing skin cancer starts with a visual inspection. Monthly self-examinations and annual physician visits are advised by the Skin Cancer Foundation and the American Cancer Society to screen for possible skin cancer. If a suspicious spot is identified, the area will first be examined by the doctor, observing its scale, shape, colour and texture, and any bleeding or scaling. Biopsies and imaging scans are the two most common forms of tests used in diagnosing skin cancer. There are many different types of biopsy, but an excisional biopsy in which the doctor extracts all growth is always enough to treat skin cancer. It is more probable that melanoma and Merkel cell carcinoma will spread. In these cases it is possible to use one of many medical imaging techniques to assess if cancer cells have metastasized to internal organs and bones. Procedures for imaging include: CT scan, X-ray, and MRI.

MARKET DYNAMICS

Factors driving the growth of the skin cancer diagnostics market are the growing incidence of skin cancer, coupled with increasing awareness about skin cancer. However, the high cost associated with diagnosis and treatment is expected to hamper the growth of the market. Moreover, increasing extensive R&D by market players is anticipated to boost the market growth.

MARKET SCOPE

The "Skin Cancer Diagnostics Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of skin cancer diagnostics market with detailed market segmentation by cancer type and diagnosis type. The skin cancer diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in skin cancer diagnostics market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The skin cancer diagnostics market is segmented on the basis of cancer type and diagnosis type. Based on cancer type, the market is segmented as melanoma and non-melanoma. On the basis of diagnosis type, the market is categorized as dermatoscopy, biopsy, genetic tests, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the skin cancer diagnostics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The skin cancer diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting skin cancer diagnostics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the skin cancer diagnostics market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the skin cancer diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from skin cancer diagnostics market are anticipated to have lucrative growth opportunities in the future with the rising demand for skin cancer diagnostics in the global market. Below mentioned is the list of few companies engaged in the skin cancer diagnostics market.

The report also includes the profiles of key players in skin cancer diagnostics market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Pfizer Inc.
  •  Bristol-Myers Squibb Company
  •  Abbott Laboratories
  •  Amgen, Inc.
  •  Merck & Co., Inc.
  •  Novartis AG
  •  F. Hoffmann-La Roche Ltd
  •  Sanofi S.A.
  •  Qiagen NV
    Sun Pharmaceutical Industries Ltd

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Skin Cancer Diagnostics Market - By Cancer Type
1.3.2 Skin Cancer Diagnostics Market - By Diagnosis
1.3.3 Skin Cancer Diagnostics Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SKIN CANCER DIAGNOSTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SKIN CANCER DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SKIN CANCER DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. SKIN CANCER DIAGNOSTICS - GLOBAL MARKET OVERVIEW
6.2. SKIN CANCER DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. SKIN CANCER DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - CANCER TYPE
7.1. OVERVIEW
7.2. CANCER TYPE MARKET FORECASTS AND ANALYSIS
7.3. MELANOMA
7.3.1. Overview
7.3.2. Melanoma Market Forecast and Analysis
7.4. NON-MELANOMA
7.4.1. Overview
7.4.2. Non-melanoma Market Forecast and Analysis
8. SKIN CANCER DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - DIAGNOSIS
8.1. OVERVIEW
8.2. DIAGNOSIS MARKET FORECASTS AND ANALYSIS
8.3. DERMATOSCOPY
8.3.1. Overview
8.3.2. Dermatoscopy Market Forecast and Analysis
8.4. BIOPSY
8.4.1. Overview
8.4.2. Biopsy Market Forecast and Analysis
8.5. GENETIC TESTS
8.5.1. Overview
8.5.2. Genetic Tests Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. SKIN CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Skin Cancer Diagnostics Market Overview
9.1.2 North America Skin Cancer Diagnostics Market Forecasts and Analysis
9.1.3 North America Skin Cancer Diagnostics Market Forecasts and Analysis - By Cancer Type
9.1.4 North America Skin Cancer Diagnostics Market Forecasts and Analysis - By Diagnosis
9.1.5 North America Skin Cancer Diagnostics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Skin Cancer Diagnostics Market
9.1.5.1.1 United States Skin Cancer Diagnostics Market by Cancer Type
9.1.5.1.2 United States Skin Cancer Diagnostics Market by Diagnosis
9.1.5.2 Canada Skin Cancer Diagnostics Market
9.1.5.2.1 Canada Skin Cancer Diagnostics Market by Cancer Type
9.1.5.2.2 Canada Skin Cancer Diagnostics Market by Diagnosis
9.1.5.3 Mexico Skin Cancer Diagnostics Market
9.1.5.3.1 Mexico Skin Cancer Diagnostics Market by Cancer Type
9.1.5.3.2 Mexico Skin Cancer Diagnostics Market by Diagnosis
9.2. EUROPE
9.2.1 Europe Skin Cancer Diagnostics Market Overview
9.2.2 Europe Skin Cancer Diagnostics Market Forecasts and Analysis
9.2.3 Europe Skin Cancer Diagnostics Market Forecasts and Analysis - By Cancer Type
9.2.4 Europe Skin Cancer Diagnostics Market Forecasts and Analysis - By Diagnosis
9.2.5 Europe Skin Cancer Diagnostics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Skin Cancer Diagnostics Market
9.2.5.1.1 Germany Skin Cancer Diagnostics Market by Cancer Type
9.2.5.1.2 Germany Skin Cancer Diagnostics Market by Diagnosis
9.2.5.2 France Skin Cancer Diagnostics Market
9.2.5.2.1 France Skin Cancer Diagnostics Market by Cancer Type
9.2.5.2.2 France Skin Cancer Diagnostics Market by Diagnosis
9.2.5.3 Italy Skin Cancer Diagnostics Market
9.2.5.3.1 Italy Skin Cancer Diagnostics Market by Cancer Type
9.2.5.3.2 Italy Skin Cancer Diagnostics Market by Diagnosis
9.2.5.4 Spain Skin Cancer Diagnostics Market
9.2.5.4.1 Spain Skin Cancer Diagnostics Market by Cancer Type
9.2.5.4.2 Spain Skin Cancer Diagnostics Market by Diagnosis
9.2.5.5 United Kingdom Skin Cancer Diagnostics Market
9.2.5.5.1 United Kingdom Skin Cancer Diagnostics Market by Cancer Type
9.2.5.5.2 United Kingdom Skin Cancer Diagnostics Market by Diagnosis
9.2.5.6 Rest of Europe Skin Cancer Diagnostics Market
9.2.5.6.1 Rest of Europe Skin Cancer Diagnostics Market by Cancer Type
9.2.5.6.2 Rest of Europe Skin Cancer Diagnostics Market by Diagnosis
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Skin Cancer Diagnostics Market Overview
9.3.2 Asia-Pacific Skin Cancer Diagnostics Market Forecasts and Analysis
9.3.3 Asia-Pacific Skin Cancer Diagnostics Market Forecasts and Analysis - By Cancer Type
9.3.4 Asia-Pacific Skin Cancer Diagnostics Market Forecasts and Analysis - By Diagnosis
9.3.5 Asia-Pacific Skin Cancer Diagnostics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Skin Cancer Diagnostics Market
9.3.5.1.1 Australia Skin Cancer Diagnostics Market by Cancer Type
9.3.5.1.2 Australia Skin Cancer Diagnostics Market by Diagnosis
9.3.5.2 China Skin Cancer Diagnostics Market
9.3.5.2.1 China Skin Cancer Diagnostics Market by Cancer Type
9.3.5.2.2 China Skin Cancer Diagnostics Market by Diagnosis
9.3.5.3 India Skin Cancer Diagnostics Market
9.3.5.3.1 India Skin Cancer Diagnostics Market by Cancer Type
9.3.5.3.2 India Skin Cancer Diagnostics Market by Diagnosis
9.3.5.4 Japan Skin Cancer Diagnostics Market
9.3.5.4.1 Japan Skin Cancer Diagnostics Market by Cancer Type
9.3.5.4.2 Japan Skin Cancer Diagnostics Market by Diagnosis
9.3.5.5 South Korea Skin Cancer Diagnostics Market
9.3.5.5.1 South Korea Skin Cancer Diagnostics Market by Cancer Type
9.3.5.5.2 South Korea Skin Cancer Diagnostics Market by Diagnosis
9.3.5.6 Rest of Asia-Pacific Skin Cancer Diagnostics Market
9.3.5.6.1 Rest of Asia-Pacific Skin Cancer Diagnostics Market by Cancer Type
9.3.5.6.2 Rest of Asia-Pacific Skin Cancer Diagnostics Market by Diagnosis
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Skin Cancer Diagnostics Market Overview
9.4.2 Middle East and Africa Skin Cancer Diagnostics Market Forecasts and Analysis
9.4.3 Middle East and Africa Skin Cancer Diagnostics Market Forecasts and Analysis - By Cancer Type
9.4.4 Middle East and Africa Skin Cancer Diagnostics Market Forecasts and Analysis - By Diagnosis
9.4.5 Middle East and Africa Skin Cancer Diagnostics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Skin Cancer Diagnostics Market
9.4.5.1.1 South Africa Skin Cancer Diagnostics Market by Cancer Type
9.4.5.1.2 South Africa Skin Cancer Diagnostics Market by Diagnosis
9.4.5.2 Saudi Arabia Skin Cancer Diagnostics Market
9.4.5.2.1 Saudi Arabia Skin Cancer Diagnostics Market by Cancer Type
9.4.5.2.2 Saudi Arabia Skin Cancer Diagnostics Market by Diagnosis
9.4.5.3 U.A.E Skin Cancer Diagnostics Market
9.4.5.3.1 U.A.E Skin Cancer Diagnostics Market by Cancer Type
9.4.5.3.2 U.A.E Skin Cancer Diagnostics Market by Diagnosis
9.4.5.4 Rest of Middle East and Africa Skin Cancer Diagnostics Market
9.4.5.4.1 Rest of Middle East and Africa Skin Cancer Diagnostics Market by Cancer Type
9.4.5.4.2 Rest of Middle East and Africa Skin Cancer Diagnostics Market by Diagnosis
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Skin Cancer Diagnostics Market Overview
9.5.2 South and Central America Skin Cancer Diagnostics Market Forecasts and Analysis
9.5.3 South and Central America Skin Cancer Diagnostics Market Forecasts and Analysis - By Cancer Type
9.5.4 South and Central America Skin Cancer Diagnostics Market Forecasts and Analysis - By Diagnosis
9.5.5 South and Central America Skin Cancer Diagnostics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Skin Cancer Diagnostics Market
9.5.5.1.1 Brazil Skin Cancer Diagnostics Market by Cancer Type
9.5.5.1.2 Brazil Skin Cancer Diagnostics Market by Diagnosis
9.5.5.2 Argentina Skin Cancer Diagnostics Market
9.5.5.2.1 Argentina Skin Cancer Diagnostics Market by Cancer Type
9.5.5.2.2 Argentina Skin Cancer Diagnostics Market by Diagnosis
9.5.5.3 Rest of South and Central America Skin Cancer Diagnostics Market
9.5.5.3.1 Rest of South and Central America Skin Cancer Diagnostics Market by Cancer Type
9.5.5.3.2 Rest of South and Central America Skin Cancer Diagnostics Market by Diagnosis
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL SKIN CANCER DIAGNOSTICS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. SKIN CANCER DIAGNOSTICS MARKET, KEY COMPANY PROFILES
12.1. PFIZER INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BRISTOL-MYERS SQUIBB COMPANY
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ABBOTT LABORATORIES
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. AMGEN, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MERCK AND CO., INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. NOVARTIS AG
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. F. HOFFMANN-LA ROCHE LTD
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SANOFI S.A.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. QIAGEN NV
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SUN PHARMACEUTICAL INDUSTRIES LTD
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Pfizer Inc.
2. Bristol-Myers Squibb Company
3. Abbott Laboratories
4. Amgen, Inc.
5. Merck & Co., Inc.
6. Novartis AG
7. F. Hoffmann-La Roche Ltd
8. Sanofi S.A.
9. Qiagen NV
10. Sun Pharmaceutical Industries Ltd
TIPRE00018116
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking